Replies to post #247719 on Biotech Values

[vinmantoo]

Astonishingly, FGEN’s 83% selloff_today_was_outdone_by AVTX, down 89% on phase-2 failure in asthma:

Ouch, talk about the Monday blues for people unfortunate enough to own them!

[TheFinalCD]

$avtx

Avalo acquires Phase 2-ready anti-IL-1ß mAb, AVTX-009, through acquisition of AlmataBio, Inc.
Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026
Executed private placement financing of up to $185 million, including initial upfront investment of $115.6 million; expected to extend cash runway into 2027
Webcast to be held tomorrow, March 28, 2024 at 8:30 a.m. E.T.

why cant they all do this

L:-)L